
Gland Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2025, titled "Gland Pharma receives approval from the United States Foodand Drug Administration (USFDA) for Angiotensin II Acetate Injection 2.5 mg/mL".
Filed with NSE ·

Gland Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2025, titled "Gland Pharma receives approval from the United States Foodand Drug Administration (USFDA) for Angiotensin II Acetate Injection 2.5 mg/mL".
6ix hasn’t read this filing yet.
Follow Gland Pharma into a list and get an email when it puts out news.
Follow Gland Pharma